Matches 201 - 250 out of 367 < 1 2 3 4 5 6 7 8 >
Match Document Document Title
5738836 Composition for stabilizing radiolabeled organic compounds  
A stabilized composition comprising an organic compound labeled with a β-emitting radionuclide and a stabilizing effective amount of a non-radiolabeled stabilizing compound selected from the group...
5736346 Induction of the acrosome reaction to evaluate the fertilization capability of mammalian sperm using a dendrimer sugar conjugate  
A method of evaluating the in vitro or in vivo fertilization capability of a given sperm sample. The method involves the steps of capacitating a sample of mammalian sperm cells followed by...
5730981 Monoclonal anti-ganglioside antibody and its preparation  
The invention relates to monoclonal antibodies of high avidity, which react specifically with the gangliosides GD3 and GQ1b, and to their use for detecting melanomas and other tumors or tissues...
5728369 Radioactive phosphorus labeling of proteins for targeted radiotherapy  
32 P- and 33 P-labeled proteins which are useful for radiotherapy are prepared by stably linking 32 P- or 33 P- containing molecules to targeting proteins in such a way that the targeting...
5723102 Process for the preparation of an organ-specific substance labeled with technetium-99m  
The invention relates to a process for the preparation of an organ-specific substance labeled with technetium-99m, in which an organ-specific substance, or an organ-specific substance which has...
5716595 Intraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragments  
Methods are provided for close-range intraoperative, endoscopic and intravascular detection and treatment of lesions, including tumors and non-malignant lesions. The methods use agents labeled with...
5714149 Crosslinked antibodies and processes for their preparation  
Cross-linked antibody conjugates are described which have at least one interchain bridge containing a reporter or effector molecule. The bridge may be the residue of a homo-or heterofunctional...
5714166 Bioactive and/or targeted dendrimer conjugates  
Dendritic polymer conjugates which are composed of at least one dendrimer in association with at least one unit of a carried material, where the carrier material can be a biological response...
5690903 Loading and conjugating cavity biostructures  
Methods for the preparation and use of a biological delivery system are disclosed. The method of preparation includes the loading of a non-biological material into a biostructure having a...
5683674 Antibody against human mucin core protein and method of preparing and using same  
Antibodies which bind to the core protein of the human polymorphic epithelial mucin glycoprotein are useful in the diagnosis of cancer.
5679318 Stable therapeutic radionuclide compositions and methods for preparation thereof  
Stable therapeutic radionuclide compositions comprising, for example, 186 Re, 188 Re and 131 I stably bound to a proteinaceous targeting moiety and suitable for human in vivo administration...
5670132 Modified radioantibody fragments for reduced renal uptake  
PEG-modified-Tc-99m-radiolabeled antibody fragments are useful for radioimmunodetection of tumors and infectious lesions and display striking reductions in renal uptake and retention of...
5660811 Isotopic tracer composition and method for making and using same  
An isotopic tracer composition and methods of making and using same for radiological evaluation of body functions and diseases in a subject and for radiological therapy. The isotopic tracer...
5648059 Methods for reducing non-target retention of immunoconjugates and metabolites thereof  
Methods for reducing non-target retention of active moieties associated with immunoconjugates and their metabolites, and more specifically, for reducing renal retention of such active moieties, are...
5648471 One vial method for labeling antibodies with Technetium-99m  
A one vial method for labeling a sulfhydryl containing antibody or antibody fragment with technetium-99m is disclosed. The method comprises contacting an antibody mixture comprised of a sulfhydryl...
5643549 Leukostimulatory agent for in vivo leukocyte tagging  
Methods and reagents for the in vivo tagging of leukocytes, and in particular lymphocytes, with a leukostimulatory agent and a linked medically useful metal ion, including a radioisotope, and...
5643550 Method of treating colorectal carcinoma lesion and composition for use therein  
This invention provides a method of imaging a colorectal carcinoma lesion in a human patient which comprises administering to the patient a monoclonal antibody capable of binding to a cell surface...
5641471 Method for preparing .sup.213 Bi for therapeutic use  
The present invention relates to the field of site directed therapy. More specifically it relates to site directed radio therapy. It provides a method for production of radioimmuno conjugates and...
5632969 N.sub.3 S.sub.2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications  
Novel N 3 S 2 chelating ligands can be chelated to a radiodetectable element, Tc or Re, and are useful for radiolabeling peptides. A group of peptides especially useful are somatostatin...
5632968 Detection of cardiovascular lesions  
This invention relates to reagents and methods for detecting and imaging cardiovascular lesions such as atherosclerotic plaques, vascular clots including thrombi and emboli, myocardial infarction,...
5630996 Two-step pretargeting methods using improved biotin-active agent conjugates  
Methods, compounds, compositions and kits that relate to pretargeted delivery of diagnostic and therapeutic agents are disclosed. In particular, methods for radiometal labeling of biotin and for...
RE35500 Direct radiolabeling of antibodies and other proteins with technetium or rhenium  
Proteins containing one or more disulfide bonds are radiolabeled with radionuclides of technetium or rhenium for use in diagnosis and treatment of a variety of pathologic conditions. Radiolabeling...
5626830 Anti-myosin mouse monoclonal antibody and method of use for diagnosis of myocardial infarction  
A monoclonal antibody or antigen binding fragment thereof which recognizes light meromyosin fragments of α- and β-type human cardiac myosin heavy chains that remain in situ after myocardial cell...
5624659 Method of treating brain tumors expressing tenascin  
Methods of treating solid and cystic tumors are disclosed. The method comprises administering to a subject afflicted with a cystic tumor an antibody which binds to tenascin in a therapeutically...
5612032 Method for diagnosing tumors using mouse monoclonal antibodies  
The subject invention relates to monoclonal antibodies and uses thereof. In particular, the invention relates to three monoclonal antibodies, referred to as B1, B3, and B5, which are useful in the...
5612016 Conjugates of antibodies and bifunctional ligands  
Provided are conjugates useful in cancer, cardiovascular or infectious disease detection and/or therapy. The conjugate is of a ligand and protein. The ligand has a moiety capable of binding to...
5609846 Radiolabelled antibody cytotoxic therapy of infectious or autoimmune disease  
Anticancer, antimicrobial and autoimmune disease, and anti-organ rejection therapy using cytotoxic agents is improved using cytokines to prevent, mitigate or reverse adverse radiation-induced or...
RE35457 Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction  
Proteins are radiolabeled with radionuclides of technetium or rhenium by a process in which the disulfide bonds of the protein are first partially reduced with stannous salts or other disulfide...
5595721 Radioimmunotherapy of lymphoma using anti-CD20  
Methods for the treatment of lymphoma by adminstration of a B cell-specific antibody are described. The invention encompasses providing to a patient both unlabeled antibodies and antibodies labeled...
5589154 Methods for the prevention or treatment of vascular hemorrhaging and Alzheimer's disease  
Methods for preventing or treating vascular hemorrhaging such as that incident to thrombolytic therapy, or characteristic of Alzheimer's and related diseases are provided. Such methods provide...
5578287 Three-step pretargeting methods using improved biotin-active agent  
Methods, compounds, compositions and kits that relate to pretargeted delivery of diagnostic and therapeutic agents are disclosed. In particular, three-step pretargeting methods are described.
5571797 Method of inducing gene expression by ionizing radiation  
The present invention provides a method for delivering ionizing radiation to specific tissues, resulting in the activation of a DNA molecule comprising a radiation responsive enhancer-promoter...
5569446 Radiohalogenation of proteins using trihalophenyl derivatives  
Compounds, useful as radiolabeling reagents, including a trihalogenated phenyl ring and having the formula ##STR1## wherein X 1 , X 2 and X 3 are halogens, one of which may be a radiohalogen, are...
5558852 Methods of treating melanomas and gliomas with monoclonal antibody Me1-14  
Methods of treating solid or cystic tumors are disclosed. The method comprises administering to a human subject afflicted with a tumor an antibody in a therapeutically effective amount, wherein the...
5540908 Detection of hypoxia with reagents containing 2-nitroimidazole compounds and methods of making such reagents  
Novel nitroaromatic compounds and immunogenic conjugates comprising a novel nitroaromatic compound and a carrier protein are disclosed. The invention further presents monoclonal antibodies highly...
5538726 Method and compositions for delivering cytotoxic agents to cancer  
A method of treating solid tumor cancer in a living being by prolonging the time a therapeutically effective agent remains in the tumor. The method comprises the steps of selecting particles of an...
5525337 Monoclonal antibody binding cell surface antigens for diagnosing cancer  
Monoclonal antibody K1 binds to an epitope on the surface of cells of some human tumors, but not to many important normal tissues. Unlike similar antigenic sites such as CA125, this epitope is not...
5514363 Method for radiolabeling antibody fragments  
A protein containing at least one pendant sulfhydryl group is directly radiolabeled with a radiometal which binds tightly to sulfhydryl groups, using one or more pendant sulfhydryl groups on the...
5512443 Second generation monoclonal antibodies having binding specificity to TAG-72 and human carcinomas and methods for employing the same  
The present invention relates to second generation monoclonal antibodies having binding specificity to a tumor associated glycoprotein having an approximate molecular weight of >10 6 d...
5498499 Peptides and antibodies that inhibit platelet adhesion  
A polypeptide analog capable of immunologically mimicking a linear hGPIIb antigenic determinant expressed when platelet-associated GPIIb-IIIa binds fibrinogen is disclosed. An antibody that...
RE35152 Method for the diagnosis and treatment of inflammation  
The invention relates to a method of detecting an inflammation site in an individual by administering to the individual a diagnostically effective amount of detectably labeled immunoglobulin or...
5489525 Monoclonal antibodies to prostate cells  
Monoclonal antibodies are provided which bind to an antigen associated with prostate cells, including prostate cancers. The monoclonal antibodies and recombinant forms thereof are used individually...
5482040 Biostaging of adenocarcinomas utilizing radiolabeled tumor-associated glycoprotein antibodies  
Broadly, the present invention is directed to a method for reliably staging adenocarcinomas typified by colorectal cancer in patients who are undergoing surgery therefor. The method includes the...
5482698 Detection and therapy of lesions with biotin/avidin polymer conjugates  
Methods of detecting and/or treating lesions in a patient are provided. The methods are an improvement over known methods comprising the steps of (a) parenterally injecting a subject with a...
5474755 Tumor associated monoclonal antibodies  
This invention relates to monoclonal antibody 88BV59 produced by B-cell lines derived from B-cells of cancer patients actively immunized with autologous tumor antigen. These monoclonal antibodies...
5470571 Method of treating human EGF receptor-expressing gliomas using radiolabeled EGF receptor-specific MAB 425  
Monoclonal antibody 425 having properties particularly beneficial for anti-tumor therapy has been raised. MAb 425 antibody binds to EGF-receptors and inhibits their bioactivities. The amount of...
5468468 Method for making a monoclonal antibody, monoclonal antibodies to α P D  
Potent neutralizing monoclonal antibodies to the human α PDGF receptor (α PDGFR) and fragments thereof are described. These monoclonal antibodies specifically bind to an epitope on α PDGFR,...
5460785 Direct labeling of antibodies and other protein with metal ions  
Proteins containing one or more dtsulfide bonds or monosulfides are labeled with medically useful metal ions for use in diagnosis and treatment of a variety of pathologtc conditions. Labeling is...
5439665 Detection and treatment of infectious and inflammatory lesions  
A polyspecific anti-leukocyte antibody conjugate for targeting foci of leukocyte accretion comprises an immunoreactive polyspecific composite of at least two different substantially monospecific...
5431897 Method of imaging colorectal carcinoma lesion and composition for use therein  
This invention provides a method of imaging a colorectal carcinoma lesion in a human patient which comprises administering to the patient a monoclonal antibody capable of binding to a cell surface...
Matches 201 - 250 out of 367 < 1 2 3 4 5 6 7 8 >